Clinical trial for Hypertension, Pulmonary
Official title Functional Pulmonary Capillary Surface Area in BPA for CTEPH
ClinicalTrials.gov ID: NCT05719415
What this study is testing
- What it's testing
- This study aims to find out how much the area of the tiny blood vessels in the lungs recovers after a treatment called balloon pulmonary angioplasty.
- Who it's for
- The study is looking for people who have chronic blood clots in their lungs and are scheduled to have a balloon procedure.
- What's involved
- Participants will have their lung blood flow measured before and after a session of balloon pulmonary angioplasty, a procedure that opens narrowed lung arteries.
- Time commitment
- The study involves measurements taken before and after a specific treatment session.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- All patients eligible for balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
You likely can't join if
- Treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers,
- Presence of patent foramen ovale
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.